MYCN and neuroblastoma: Conversely, reduced T-cell infiltration has been observed in primary neuroblastoma tumors with MYCN amplification, together with lower IFN pathway activity and chemokine expression (15), suggesting that MYCN amplification could impact immune cell recruitment.